Target intelligence / Profile preview

60S ribosomal protein L23 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

"60S ribosomal protein L23 pseudogene" refers to a processed pseudogene derived from the coding gene for 60S ribosomal protein L23 (RPL23). Pseudogenes are non-functional copies of genes that have lost their protein-coding ability due to mutations or lack of regulatory sequences[1][3][8]. This pseudogene does not code for a functional protein and is not involved in protein synthesis or cellular processes. There are many such pseudogenes in the human genome, especially for ribosomal proteins, reflecting gene duplication and genome evolution[1][8]. They are not considered valid therapeutic targets or relevant to drug discovery efforts. If your intent is to refer to the *functional* protein (RPL23), that is a component of the 60S ribosomal subunit essential for protein synthesis, but the specific entry here (ENSG00000253800) is not the functional protein-coding gene but rather a *pseudogene* copy—hence not a true target for therapeutic intervention[1][3][8].

Other names
RPL23P (predicted)Ribosomal protein L23 pseudogeneOther aliases like "RPL23AP*" (for specific processed pseudogenes in databases)

Beyond the preview

Go deeper on 60S ribosomal protein L23 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 60S ribosomal protein L23 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call